Indiana 2023 Regular Session

Indiana Senate Bill SB0214

Introduced
1/10/23  
Refer
1/10/23  
Report Pass
1/19/23  
Engrossed
1/25/23  
Refer
2/7/23  
Report Pass
3/28/23  
Enrolled
4/4/23  
Passed
4/20/23  
Chaptered
4/20/23  

Caption

Standing order for overdose intervention drugs.

Impact

The implementation of SB0214 is expected to significantly impact state health laws by promoting a public health approach toward the opioid crisis. The bill establishes legal protections for individuals who administer overdose intervention drugs in good faith, shielding them from prosecution for drug possession. This change is poised to facilitate a more collaborative effort among healthcare providers, educators, and community members in addressing the epidemic of opioid abuse and enhancing community health outcomes.

Summary

Senate Bill 0214 seeks to address the growing issue of opioid overdoses in Indiana by allowing prescribers to issue standing orders for overdose intervention drugs, such as naloxone, without needing to examine the individual to whom the drug may be administered. The bill establishes specific conditions under which these prescriptions can be made, which includes education about overdose response and referrals to drug addiction treatment programs. By broadening access to overdose intervention drugs, SB0214 aims to empower individuals in preventing opioid-related fatalities and promoting immediate help in overdose situations.

Sentiment

The general sentiment surrounding SB0214 has been largely supportive, with many lawmakers and health advocates recognizing the necessity of such measures in the face of increasing overdose rates. Public health organizations and advocacy groups have voiced approval, highlighting the importance of reducing barriers to accessing life-saving medications. However, there are concerns among opponents regarding the potential for misuse and the adequacy of training provided to individuals administering such drugs, reflecting a cautious approach to the implementation of the bill's provisions.

Contention

A notable point of contention regarding SB0214 involves the balance between accessibility and safety. While many support the intent to save lives through increased access to naloxone, critics have raised questions about whether the necessary educational components and protocols will be adequately put in place to ensure safe usage among laypeople. Additionally, the bill's provisions regarding law enforcement's non-intervention in the event of good faith actions may stir debate regarding the broader implications for drug policy enforcement in the state.

Companion Bills

No companion bills found.

Previously Filed As

IN SB0221

Pharmacist treatment by standing order.

IN HB1087

Overdose reversal medication.

IN HB572

Public Health - Opioid Overdose Reversal Drugs

IN SB793

Public Health - Opioid Overdose Reversal Drugs

IN HB0361

Drug Overdose Training Amendments

IN HB0205

Substance Use Intervention Amendments

IN SB308

Drug overdose and drug overdose deaths; VDH to develop plan for opioid overdose response.

IN HB794

Drug overdose and drug overdose deaths; VDH to develop plan for opioid overdose response.

IN SB0190

Grants for violence intervention programs.

IN SB119

Relative to Medicaid pharmaceutical services and relative to standing orders for Ivermectin.

Similar Bills

HI HB2258

Relating To Mental Health Intervention.

HI SB3078

Relating To Mental Health Intervention.

HI SB709

Relating To Mental Health.

CA AB2233

Behavioral health treatment plans.

MI HR0082

A resolution to declare May 5-9, 2025, as Tardive Dyskinesia Awareness Week in the state of Michigan.

DE SCR66

Designating The First Full Week Of May As "tardive Dyskinesia Awareness Week" In Delaware.

CA SCR68

Tardive Dyskinesia Awareness Week.

CA SR103

Relative to Tardive Dyskinesia Awareness Week.